IRIS
GEROLDI, DIEGO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.261
AS - Asia 2.318
EU - Europa 2.126
SA - Sud America 257
AF - Africa 88
OC - Oceania 6
Totale 8.056
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.205
CN - Cina 1.192
SG - Singapore 516
IE - Irlanda 463
UA - Ucraina 300
FI - Finlandia 271
DE - Germania 268
RU - Federazione Russa 227
BR - Brasile 207
HK - Hong Kong 197
VN - Vietnam 190
GB - Regno Unito 159
FR - Francia 116
IT - Italia 109
SE - Svezia 96
IN - India 62
ZA - Sudafrica 60
CA - Canada 34
JP - Giappone 27
BE - Belgio 26
PL - Polonia 25
BD - Bangladesh 22
IQ - Iraq 21
NL - Olanda 19
AR - Argentina 17
TR - Turchia 17
ES - Italia 16
MX - Messico 14
ID - Indonesia 10
SA - Arabia Saudita 10
UZ - Uzbekistan 10
MA - Marocco 9
CO - Colombia 8
CZ - Repubblica Ceca 6
EC - Ecuador 6
JO - Giordania 6
MY - Malesia 6
PK - Pakistan 6
AU - Australia 5
CL - Cile 5
PH - Filippine 5
VE - Venezuela 5
KE - Kenya 4
LT - Lituania 4
AT - Austria 3
IL - Israele 3
NP - Nepal 3
PE - Perù 3
PY - Paraguay 3
AE - Emirati Arabi Uniti 2
BO - Bolivia 2
BY - Bielorussia 2
CH - Svizzera 2
CR - Costa Rica 2
DZ - Algeria 2
ET - Etiopia 2
LY - Libia 2
MU - Mauritius 2
NO - Norvegia 2
PT - Portogallo 2
QA - Qatar 2
RO - Romania 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
SY - Repubblica araba siriana 2
TJ - Tagikistan 2
TN - Tunisia 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BW - Botswana 1
CU - Cuba 1
DO - Repubblica Dominicana 1
GA - Gabon 1
HU - Ungheria 1
IR - Iran 1
KG - Kirghizistan 1
KH - Cambogia 1
KR - Corea 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LV - Lettonia 1
MK - Macedonia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PA - Panama 1
PS - Palestinian Territory 1
SV - El Salvador 1
UY - Uruguay 1
ZM - Zambia 1
Totale 8.056
Salva come PNG Salva come JPEG
Città #
Dublin 463
Chandler 457
San Jose 403
Jacksonville 338
Singapore 285
Nanjing 272
Ashburn 240
Beijing 218
Hong Kong 191
Dallas 168
Boardman 125
Ann Arbor 116
Nanchang 104
Helsinki 97
Los Angeles 94
Munich 80
Princeton 80
Lawrence 73
Hebei 70
Shenyang 69
New York 68
Changsha 67
Medford 67
Lauterbourg 58
Hanoi 54
Ho Chi Minh City 54
Jiaxing 54
Johannesburg 52
Wilmington 50
Moscow 45
Tianjin 44
Hangzhou 42
Shanghai 37
Buffalo 35
Council Bluffs 31
Orem 29
Turku 29
Woodbridge 29
São Paulo 27
Brussels 26
Milan 25
Tokyo 24
Seattle 22
Verona 22
Norwalk 18
Warsaw 17
Chennai 16
Brooklyn 15
London 13
Piscataway 13
Redondo Beach 13
Des Moines 12
Manchester 12
Montreal 12
Pavia 12
Toronto 12
Denver 11
Rio de Janeiro 11
Santa Clara 11
Auburn Hills 10
Fairfield 10
Frankfurt am Main 10
Poplar 10
Da Nang 9
Haiphong 9
Houston 9
Atlanta 8
Mumbai 8
Tashkent 8
Amsterdam 7
Jinan 7
Washington 7
Zhengzhou 7
Baghdad 6
Istanbul 6
Jeddah 6
Ningbo 6
Stockholm 6
Taizhou 6
Berlin 5
Biên Hòa 5
Bắc Ninh 5
Campinas 5
Curitiba 5
Kunming 5
Mexico City 5
Naples 5
Amman 4
Cape Town 4
Changchun 4
Chicago 4
Falkenstein 4
Hanover 4
Kuala Lumpur 4
Lanzhou 4
Medellín 4
Nairobi 4
Paris 4
Phoenix 4
Pune 4
Totale 5.379
Salva come PNG Salva come JPEG
Nome #
Significance of apolipoprotein(a) phenotypes in acute coronary syndromes: relation with clinical presentation. 164
Plasma eotaxin concentrations are associated with angiographic severity of coronary artery disease 157
Significato prognostico dei livelli plasmatici di osteopontina in pazienti con angina pectoris stabile 150
Approccio genetico-clinico alla cardiopatia ischemica: analisi di 14 casi familiari. 147
Absence of Kir6.1/KCNJ8 mutations in Italian patients with abnormal coronary vasomotion 145
Relationship between apolipoprotein(a) size polimorphism and coronary heart disease in overweight subjects 142
Diabetes mellitus and silent myocardial ischemia in patients with coronary artery disease: comparison between patients with and without simptoms during provocative test. 140
374T/A polymorphism of the RAGE gene promoter in relation to severity of coronary atherosclerosis 139
La chemochina regolatoria eotaxina-3 quale nuovo fattore predittivo di outcome cardiovascolare in pazienti con angina pectoris stabile 138
RAGE : a central player in nondiabetic vascular disease 137
Decreased NT-3 plasma levels and platelet serotonin content in patients with hypochondriasis 137
Relationship between plasma levels of soluble receptor for advanced glycation end products (sRAGE) and coronary artery disease 136
Analisi mutazionale di Kir6.1/KCNJ8 in pazienti con angina vasospastica 134
Apo(a) isoforms: a genetic marker for progression of coronary atherosclerosis. 133
Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men 132
A novel Val734Ile variant in the ABCC9 gene associated with myocardial infarction 132
QT interval duration in apparently healthy men is associated with depression-related personality trait neuroticism 131
The apolipoprotein(a) component of lipoprotein(a) mediates binding to laminin:contribution to selective retention of lipoprotein(a) in atherosclerotic lesions. 130
Decreased plasma levels of soluble receptor for advanced glycation end-products in patients with essential hypertension 130
Circulating levels of osteopontin predicts future cardiac events in patients with chronic stable angina 130
Forma solubile del recettore dei prodotti finali di glicazione avanzata (sRAGE) ed aterosclerosi coronarica 130
Association between low-molecular weight apolipoprotein(a) isoforms and obesity in Italian women 129
Association of lipoprotein(a) levels and apolipoprotein(a) phenotypes with coronary heart disease in patients with essential hypertension 129
Analysis of the apolipoprotein(a) size polymorphism in patients with systemic lupus erythematosus. 129
Association of lipoprotein(a) levels and apolipoprotein(a) phenotypes with coronary artery disease in Type 2 diabetic patients and in non-diabetic subjects 129
Raised plasma nerve growth factor levels associated with early-stage romantic love 128
The regulatory chemokine eotaxin-3 is a novel predictor of cardiovascular outcome in patients with coronary artery disease 126
Analysis of the apolipoprotein(a) size polymorphism in patients with systemic lupus erythematosus 124
Matrix metalloproteinase 2 may be a marker of microangiopathy in children and adolescents with type 1 diabetes 122
Association of plasma eotaxin levels with the presence and extent of angiographic coronary artery disease 122
Analysis of the apoliporotein(a) size polymorphism in patients with systemic lupus erythematosus 121
Matrix metalloproteinase 2 may be a marker of microangiopathy compared to metalloproteinase 9 in children and adolescents with type 1 diabetes mellitus: A 5 year follow-up study 119
High levels of soluble receptor for advanced glycation end products may be a marker of extreme longevity in humans 118
Action of piracetam and clonidine on different mitochondrial populations from hippocampus 117
Cerebral ischemia and peripheral energy dysfunction in lymphocytes 116
Disfunzione erettile come predittore di eventi cardiovascolari maggiori in diabetici con coronaropatia silente angiograficamente documentata 113
Assessment of asymptomatic coronary artery disease in apparently uncomplicated type 2 diabetic patients: a role for lipoprotein(a) and apolipoprotein(a) polymorphism. 112
Association between apolipoprotein(a) phenotypes and coronary heart disease at a young age. 111
Elevated plasma levels of lipoprotein(a) in psychiatric patients: a possible contribution to increased vascular risk 108
ATPases enzyme activities during ageing in different types of somatic and synaptic plasma membranes from rat frontal cerebral cortex 106
Enzyme activities in perikaryal and synaptic mitochondrial fractions from rat hippocampus during development 106
Apolipoprotein(a) phenotypes are reliable biomarkers for familial aggregation of coronary heart disease 104
Relationship between erectile dysfunction and silent myocardial ischemia in apparently uncomplicated type 2 diabetic patients 103
High Lp(a) levels and atherogenic isoforms in patients with acute coronary sindrome 103
Markers of eosinophilic inflammation and risk prediction in patients with coronary artery disease 103
Apolipoprotein(a) phenotypes and their predictive value for coronary heart disease: identification of an operative cut-off of apolipoprotein(a) polymorphism. 101
Circulating levels of soluble receptor for advanced glycation end products in neurodegenerative and vascular dementia 99
Silent myocardial ischemia in diabetic and nondiabetic patients with coronary artery disease. 99
Functional proteomics of energy-linked enzymes in lymphocytes after stroke. 97
The -374T/A RAGE polymorphism protects against future cardiac events in nondiabetic patients with coronary artery disease. 96
Matrix metalloproteinase 2 may be a marker of microangiopathy in children and adolescents with type 1 diabetes mellitus 96
Prognostic significance of plasma osteopontin levels in patients with chronic stable angina 96
Matrix metalloproteinase 2 and 9 evaluation in patients with or without diabetes during acute coronary syndrome and after the acute event 92
Matrix metalloproteinase 2 may be a marker of microangiopathy compared to metalloproteinase 9 in children and adolescents with type 1 diabetes mellitus: a 5-year follow-up study 92
Genetic loading on human loving styles 92
Restenosis after intracoronary stent placement: can apolipoprotein(a) polymorphism play a role? 91
Soluble receptor for advanced glycation end products: from disease marker to potential therapeutic target 90
Increased Plasma Aldosterone Concentrations in Patients with Clinical Depression 89
Fenotipi di apolipoproteina(a) come indicatori di suscettibilità genetica per rischio cardiovascolare in medicina del lavoro 85
Factors involved in drug interference on enzyme activities of three mitochondrial populations from rat hippocampus 83
The apolipoprotein(a) size polymorphism is assocated with Alzheimer's disease and vascular dementia 83
Erectile dysfunction and angiographic extent of coronary artery disease in type II diabetic patients 78
Metalloproteinase-2 and -9 in diabetic and nondiabetic subjects during acute coronary syndromes 77
Relationship between platelet serotonin content and rejections of unfair offers in the ultimatum game. 76
Peripheral energy dysfunction in cerebral ischemia: focus on lymphocytes. 76
Energy metabolism of mitochondria after ischemia and recovery times during aging and peripheral energy dysfunction in stroke patients: focus on lymphocytes 75
Mitochondrial Energy Metabolism of Brain and Lymphocytes after Ischemia and Recovery during Aging 75
Prevalenza di elevati livelli di Lp(a) e di isoforme aterogene in un gruppo di pazienti del Nord Italia con sindrome coronarica acuta 74
Valutazione delle metalloproteasi 2 e 9 in pazienti con o senza diabete durante sindrome coronarica acuta e dopo evento acuto 74
Relationship between apolipoprotein(a) size polymorphism and coronary heart disease in overweight subjects 72
Energy metabolism of lymphocytes from acute stroke patients 72
Lymphocytes bioenergetics after stroke: a functional proteomic study 72
Mitochondrial Energy Metabolism of Brain and Lymphocytes after Ischemia and Recovery during Aging 67
Totale 8.081
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.997
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.997
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202115 0 0 0 0 0 0 0 0 0 0 0 15
2021/2022326 7 3 9 8 2 5 8 20 16 19 49 180
2022/20231.338 139 107 17 98 149 124 0 78 556 17 34 19
2023/2024424 77 85 11 26 34 95 4 37 3 13 19 20
2024/20251.128 18 82 50 32 34 38 44 80 290 33 149 278
2025/20262.642 219 140 258 304 325 143 635 111 199 165 109 34
Totale 8.081